Viral infection is commonly associated with virus-driven hijacking of host proteins. Here we describe a novel mechanism by which influenza virus affects host cells through the interaction of influenza non-structural protein 1 (NS1) with the infected cell epigenome. We show that the NS1 protein of influenza A H3N2 subtype possesses a histone-like sequence (histone mimic) that is used by the virus to target the human PAF1 transcription elongation complex (hPAF1C). We demonstrate that binding of NS1 to hPAF1C depends on the NS1 histone mimic and results in suppression of hPAF1C-mediated transcriptional elongation. Furthermore, human PAF1 has a crucial role in the antiviral response. Loss of hPAF1C binding by NS1 attenuates influenza infection, whereas hPAF1C deficiency reduces antiviral gene expression and renders cells more susceptible to viruses. We propose that the histone mimic in NS1 enables the influenza virus to affect inducible gene expression selectively, thus contributing to suppression of the antiviral response.
Histones are essential regulators of genome function in eukaryotic cells 1, 2 . The amino-terminal domain of histones (the histone tail) provides a scaffold for the assembly of protein complexes controlling gene activity 3 . This role of a histone tail is achieved largely by post-translational histone modifications, catalysed by distinct modifying enzymes 4 . The combination of diversely modified histone tails establishes gene-region-specific patterns that, upon recognition by histone-binding proteins, contribute to the regulation of gene replication 5 , repair 6 and transcription 7 . The ability of histone tails to guide gene function indicates the possibility of targeted control of gene expression by artificial or naturally occurring molecules that can structurally and/or functionally mimic the histone tail. The former possibility has been demonstrated by studies that show the ability of synthetic compounds to interfere with inducible gene expression by abolishing the interaction between the acetylated histone H4 and the BET family of transcriptional regulators 8, 9 . Histone binding to transcriptional regulators could also be interrupted by exogenous cell-permeable histone peptides 10, 11 . This approach underscores the possibility of a competition between endogenous and exogenous histone tails for the common binding partners. Indeed, the histone H3 tail-like sequence (histone mimic) within histone methyltransferase G9a can compete, in a modificationdependent fashion, for binding to the histone-bound heterochromatin protein 1 (HP1) 12 . Overall, the 3-5-amino-acid-long sequences that match various parts of the histone tail can be found in numerous eukaryotic and prokaryotic proteins; however, the role of these presumptive histone mimics in the regulation of gene activity remains unknown.
Influenza virus NS1 carries a histone H3-like sequence
Pathogens have a known ability to interfere with vital processes in the host cells by mimicking regulatory components of host protein networks 13 . In searching for naturally occurring histone mimics with a gene regulatory capability, we screened in silico for pathogen-derived proteins that have a known or predicted capacity to accumulate within the nuclei of infected cells, and bear a histone-tail-like unstructured domain at the amino or carboxy termini. One of these proteins was found to be the influenza A virus NS1 protein that suppresses host response to influenza virus 14 . Depending on the viral subtype, NS1 is a 219-237-amino-acid-long protein 14 . NS1 is not essential for formation of the viral particle but is critical for counteracting the antiviral cell response 14, 15 . In the absence of NS1, influenza is greatly attenuated 15 . Suppression of antiviral host response by NS1 relies partly on the ability of NS1 to interfere with cytosolic signalling processes that regulate the expression of type I interferon genes [16] [17] [18] [19] . Additionally, the NS1 protein can affect host gene expression by interfering with RNA splicing and messenger RNA export [20] [21] [22] [23] . We found that NS1 of influenza A (H3N2) virus carries a sequence that resembles the histone H3 tail. Similar to the histone tail, the C terminus of NS1 comprises a non-structured and potentially highly interactive domain 24, 25 (Fig. 1a) . Although this unstructured C-terminal domain is present in most of the human influenza A variants (Fig. 1a) , only NS1 from H3N2 subtype (hereafter defined as NS1) possesses the ARSK sequence (amino acids 226-229) that is chemically analogous to the 1 
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4 sequence that comprises the lysine 4 site (H3K4) of histone H3 (Fig. 1a) . The similarity between histone H3 and NS1 tails is further strengthened by the ability of the NS1 tail to serve as a substrate for histone-modifying enzymes in vitro. Incubation of the NS1 tail peptide with lysine methyltransferase Set1 complex or Set7/9 in the presence of S-adenosylmethionine resulted in incorporation of the methyl mark into the peptide (Fig. 1b, upper panel) . Accordingly, substitution of lysine 229 to arginine (K229R) prevented methylation. These results, as well as the ability of histone acetyltransferase TIP60-which acetylates histone H3 lysine 4 in yeast 26 -to acetylate the NS1 peptide at K229 (Fig. 1b, upper panel) , support the histone mimicry by NS1. The ability of the H3K4-like sequence within the NS1 tail to serve as a substrate for chosen histone-modifying enzymes has been further confirmed by using recombinant GST fusion NS1 protein (Fig. 1b, middle panel) . Finally, the H3K4-like site within NS1 could be methylated or acetylated in virally infected cells. Using a custom-made antibody against dimethylated lysine 229 in NS1 (NS1me2; Supplementary Fig. 1 ), or acetyl-specific antibody 27 , we found the presence of methylated and acetylated NS1 in infected human cells (Fig. 1b, lower  panel) . Point mutation of the NS1 gene that causes K229R substitution prevented modification (Fig. 1b, lower panel) . It is likely that members of the H3K4 methyltransferase and acetyltransferase enzymes, that can modify NS1 in vitro, are responsible for NS1 modification in vivo. However, in view of the known redundancy between multiple H3K4 modifying complexes 4, [28] [29] [30] , identification of a sole NS1 modifying enzyme seems unlikely.
NS1 interacts with transcript-elongating proteins
Our experiments show the presence of a histone mimic within the NS1 tail. In histones, the unmodified or modified histone tail contributes to the assembly of chromatin protein complexes [31] [32] [33] . The nature of the histone-tail-binding proteins is commonly revealed by the identification of nuclear proteins that bind to immobilized histone peptides during affinity purification 34 . Using this approach ( Supplementary  Fig. 2 ), we searched for human nuclear proteins that bind to the NS1 tail peptide (amino acids 220-230). To control for the specificity of binding we used a scrambled peptide with an amino acid composition identical to NS1. Mass-spectrometry analysis of NS1-tail-bound proteins revealed the association of the NS1 tail with polypeptides that belong to the human PAF1 transcription elongation (hPAF1C) and CHD1 chromatin remodelling complexes ( Supplementary Fig. 2 ). Binding of the NS1 tail to human PAF1, parafibromin (CDC73), SNF2l and CHD1 were validated by western blotting (Fig. 1c) . In support of the histone mimicry by the NS1 tail, we observed the histone-H3-like pattern of the NS1 tail binding to CHD1 in vitro. The chromodomain of human CHD1 binds specifically to di-or trimethylated lysine 4 of histone H3 (ref. 35) . Similarly, the full-length CHD1 or the purified double-chromodomain binds selectively to di-or trimethylated NS1 peptide, but not to unmodified or acetylated NS1 tail (Fig. 1d) .
To start assessing the role of the NS1 histone mimic in the regulation of chromatin complexes, we focused our attention on hPAF1C. We chose this on the basis of several factors. First, hPAF1C is a potent regulator of RNA elongation 36 , a co-transcriptional process that contributes significantly to pathogen-induced gene expression 11, 37 . Second, PAF1C has been implicated in the regulation of stress-induced genes in yeast 38 that could be functionally equated to pathogeninduced genes in mammalian cells. Third, opposite to CHD1 that binds to the NS1 tail in a methyl-dependent fashion, purified hPAF1C binds to unmodified as well as modified NS1 tail ( Supplementary Fig. 3a , left panel), thus making this interaction potentially more versatile. The interaction of hPAF1C with the NS1 tail is sequence-dependent. Neither NS1 tail of the H5N1 influenza virus, the scrambled NS1 peptide, nor the truncated NS1 tail that lacks the H3K4-like sequence were able to bind to hPAF1C ( Supplementary Fig. 3b ).
hPAF1C consists of six distinct subunits (PAF1, LEO1, CDC73 (also called parafibromin), SKI8 (also called WDR61), CTR9, RTF1) that have different roles in the interaction between hPAF1C and its binding partners, including RNA polymerase II (RNA Pol II) 36, 39, 40 . To identify the primary NS1-tail-interacting hPAF1C subunit(s), we tested binding of the NS1 tail to purified recombinant individual hPAF1C subunits. We found that human PAF1 is the primary binder of the unmethylated or methylated NS1 tail, but not the control peptide that lacks the histone mimic (Fig. 1e, left ARTICLE RESEARCH acetylated NS1 tail, thus pointing to a possible in vivo regulation of NS1 binding to PAF1 by a methyl/acetyl-switch mechanism. Finally, NS1 interacts with PAF1 in vivo. Immunoprecipitation of NS1 or PAF1 from infected cell extract revealed the existence of an NS1-PAF1 complex ( Supplementary Fig. 3c ). Our findings show that direct binding of the NS1 histone mimic to PAF1 is responsible for the association of NS1 with hPAF1C. Interaction of hPAF1C with the NS1 histone mimic raised the possibility of hPAF1C binding to the histone H3 tail. Although the interaction of hPAF1C with RNA Pol II and other transcriptional regulators is well established 36, 39, 40 , the direct association between hPAF1C and histone H3 has not been documented. We found that unmodified and methylated histone H3 tail peptides, but not the scrambled control peptide, bind to hPAF1C ( Supplementary Fig. 3a , right panel) or to purified PAF1 protein (Fig. 1e, right panel) . Similar to the NS1 histone mimic, the acetylated histone H3 tail did not bind to either hPAF1C components.
The ability of homologous tails of NS1 and histone H3 to interact directly with hPAF1C indicated a possibility of virus-mediated hijacking of the transcription elongation machinery from the host genes. We found that NS1 accumulates in the nuclei of the infected human cells ( Supplementary Fig. 4a Supplementary  Fig. 4b ). The salt-extraction profile of NS1 from nuclei of infected cells showed association of NS1 with chromatin ( Supplementary Fig. 4c ).
To assess the position of NS1 on chromatin during viral infection, we generated a recombinant virus (Flag-NS1) that expresses Flag-tagged NS1 protein ( Supplementary Fig. 5a, b) . Genome-wide analysis of the Flag-NS1 binding at 12 h after infection revealed the presence of NS1 on induced antiviral gene promoters (Supplementary Tables 1 and 2 ).
In infected cells, NS1 is enriched at promoters characterized by the presence of H3K4me3 and RNA Pol II (Fig. 2a) . The pattern of NS1 distribution on its targets parallels the distribution of hPAF1C (Fig. 2a) . Collectively, these data revealed a strategic position of NS1 at sites of active antiviral gene transcription.
NS1 histone mimic controls antiviral gene expression
The interaction between the NS1 tail and hPAF1C has two complementary functions that may support viral infection. The virus probably uses the NS1-hPAF1C interaction to target sites of active transcription. The short interfering RNA (siRNA)-mediated PAF1 deficiency resulted in 30% reduction of NS1 levels at the transcriptional start sites of the NS1-bound genes in infected cells (Fig. 2b) . The specific role of PAF1 in recruitment of NS1 was supported by unaltered NS1 binding to its gene targets in cells treated with CHD1-specific siRNA (Fig. 2b) . These findings revealed a previously unknown ability of the influenza virus to use host PAF1 to position viral NS1 protein at sites of active gene transcription.
Once targeted to transcriptionally active loci, as defined by RNA Pol II levels cross-referenced to the infected cell transcriptome (Supplementary Tables 1 and 2 ), NS1 interferes with PAF1 and RNA Pol II abundance at target genes. As exemplified by virus-induced IFIT1 and IFI6 genes, infection with the wild-type influenza virus resulted in decreased PAF1 and RNA Pol II levels at the transcriptional end sites (TES) and to a lesser extent at the transcriptional start sites (TSS) of the genes, as compared with PAF1-binding mutant virus (DPAF) (Fig. 2c) . This pattern of PAF1, RNA Pol II and H3K4me3 distribution is indicative of impaired transcriptional elongation.
To determine the impact of the NS1 tail on the dynamics of antiviral gene transcription, we conducted a genome-wide nuclear 'run-on' analysis (global run-on sequencing, GRO-seq) 41 of cells infected with the wild-type or mutant viruses that cannot bind to human PAF1 (DPAF). In the absence of infection, we observed accumulation of RNA species that map to the TSS of antiviral genes and low levels of RNAs that map to the gene body (Fig. 3a) . Accumulation of TSSassociated short RNAs is a common feature of rapidly inducible genes that maintain a paused/poised state in the absence of an inducer 41 .
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Infection with the DPAF virus resulted in a marked increase in levels of RNA transcripts that map to the TSS as well as to the downstream gene region. The high abundance of transcripts associated within the gene body is indicative of effective RNA elongation, which has an essential role in regulation of the pathogen-driven host response 11, 37 . Compared to cells infected with DPAF virus, the cells infected with wild-type virus displayed slightly reduced levels of TSS-associated RNAs but greatly diminished levels of transcripts associated with the gene body and 39 end region (Fig. 3a) . This pattern is indicative of impaired transcriptional elongation and is consistent with defective elongation in other experimental settings 42, 43 . The differences between the impact of DPAF and wild-type viruses on the global dynamics of antiviral gene transcription are exemplified by differences in transcription of selected antiviral genes (Fig. 3a, right panel) . Infection with either wild-type or DPAF virus has no effect on transcriptional dynamics of housekeeping genes and genes not affected by viral infection (Fig. 3b) .
The ability of NS1 to control directly hPAF1C-dependent transcriptional elongation was further supported by the analysis of the impact of the NS1 tail on hPAF1C-driven RNA elongation in vitro. In this assay, a chromatinized DNA template, supplemented with selected transcription factors and histone-modifying enzymes, supports hPAF1C-mediated transcription in a fashion that faithfully reproduces transcriptional elongation in vivo 36 ( Fig. 4a) . We found that NS1 has a negative impact on hPAF1C function (Fig. 4b) . The comparison between the amount of in vitro synthesized RNA in the absence or presence of hPAF1C shows the ability of hPAF1C to boost RNA synthesis (Fig. 4b) . Addition of purified NS1 (Supplementary Fig. 5c ) to the transcription reaction reduced the amount of synthesized RNA to background levels (Fig. 4b) . Addition of purified NS1 that lacks the PAF1-binding sequence had no effect on RNA synthesis (Fig. 4b) . Both wild-type NS1 and NS1 that lacks the PAF1 binding sequence have no impact on transcription of non-chromatinized template in vitro (Supplementary Fig. 6 ). This selective and direct impact of NS1 on virus-induced gene expression has been further supported by a lack of NS1 requirement for the association between the viral and the host RNA polymerases in infected cells 44, 45 ( Supplementary Fig. 7 ). Our findings provide unambiguous proof for the ability of the NS1 tail to interfere directly with hPAF1C-driven transcription of antiviral genes.
hPAF1C controls antiviral gene expression and infection
The significance of NS1-hPAF1C interaction during infection was evaluated by two independent experimental approaches. Deletion of the hPAF1C binding sequence in NS1 resulted in reduced viral titres of the DPAF virus as compared to those of the virus carrying fulllength NS1 (Supplementary Fig. 8 ). This finding is in agreement with the previously reported positive role of the NS1 carboxy terminus in influenza A virulence 46 . We also revealed the central role of hPAF1C in transcriptional response induced by various viruses, as well as by the viral RNA analogue poly(I:C) and type I interferon. To study the impact of PAF1 on influenza-induced antiviral gene expression we used the NS1-deficient influenza virus (PR8/DNS1) that elicits an extremely potent antiviral response and is therefore particularly useful to study host factors that regulate the antiviral response 14, 15 . Infection with PR8/ DNS1 of control siRNA-treated cells resulted in a strong upregulation of numerous antiviral genes (Fig. 5a ). This response was reduced in PAF1-deficient cells (Fig. 5a, Supplementary Fig. 9 , left panel, and Supplementary Table 3 ). The negative effect of PAF1 deficiency on antiviral response is not a consequence of impaired virus life-cycle caused by a reduction in viral gene expression (Supplementary Fig. 10 ).
PAF1 deficiency also attenuated the transcriptional response to wild-type influenza A H1N1 ( Supplementary Fig. 11, left panel) . The general positive role of PAF1 in antiviral gene expression was underscored by reduced expression of antiviral genes in PAF1-deficient cells infected with vesicular stomatitis virus (VSV) as well as cells treated with poly(I:C) ( Supplementary Fig. 11 and Supplementary Tables 4-6). PAF1 deficiency also downregulates the transcriptional response to type I interferon that governs the antiviral immunity (Fig. 5b , Supplementary Fig. 9 , right panel and Supplementary Table 7 ). The impaired antiviral response by PAF1-deficient cells contributes to a nearly tenfold increase of NS1-deficient PR8/DNS1 virus replication, IL29  ISG15  CCL5  ZNFX1  CCL4L1  SERPINE1  BAMBI  HCG4  ULBP2  RAET1L  SNPH  LOC728014  FAM46A  LRRN3  MXD1  NP  SOD2  PLAUR  ISG20  ZC3HAV1  NFKBIZ  CITED2  OAS3  SDC4  IDO1  HERC5  CCL4L2  DDX58  CCL3  OASL  SCARNA8  PRIC285  CCL3L1  IFI44L  IFITM3  IFI44  ZFP36  IFIT3  CCL3L3  LOC728835  SERTAD1  ARL4A  OAS2  BIRC3  TAC3  KLF4  FOSB  SNAI1  LOC645558  ARC  FAM46C MX2  IFI6  OAS2  DDX58  ISG15  CFH  ZNFX1  CTGLF7  IFITM1  LOC100128274  B2M  OAS1  KIAA1618  PARP14  PARP9  XAF1  OAS3  IFI16  TNFSF10  IDO1  LAMP3  SP100  PLEKHA4  CYP2J2  NT5C3  DDX60L  BST2  STAT1  HLA-E  IFIT3  IFI27  IFITM3  IFI44L 
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as compared to infected control cells (Fig. 5c) . The impact of PAF1 deficiency on antiviral gene expression is selective. PAF1 deficiency does not alter the expression of housekeeping genes (Supplementary Fig. 12 and Supplementary Table 8 ).
Concluding remarks
We have shown that H3N2 influenza A virus interferes with host gene expression by exploiting the very basic principles of the epigenetic control of gene regulation. By mimicking the histone H3K4 sequence, which has a key role in positive regulation of gene transcription, the influenza virus gains access to histone-interacting transcriptional regulators that govern inducible antiviral gene expression. The histone-like unstructured NS1 tails are present in the majority of human influenza A isolates, but their primary sequence differs between viruses. The presence of potentially reactive amino acid residues within the unstructured NS1 tails and the nuclear localization of NS1 predict a multitude of nuclear proteins interacting with influenza NS1 in a sequence-and/or modification-specific fashion.
In extension of the histone code that has provided a conceptual framework for understanding chromatin-based gene regulation [47] [48] [49] , we propose the existence of the 'NS1 code' that guides influenza virus interference with host chromatin. The interference with chromatin function may complement other immunosuppressive functions of NS1 and provide the influenza virus with an opportunity to affect host gene expression in a highly selective fashion by recognizing and using epigenetic patterns of the host cells. This mechanism may contribute to the influenza-variant-specific pathogenesis and disease progression that differ between viruses carrying the histone-like NS1 tail and those viruses, such as human H1N1 (including pandemic 2009 virus), that lack the NS1 tail 50 . It is possible that by targeting the actively transcribed antiviral genes, the NS1 tail helps influenza to balance its virulence against the preservation of the infected cell function. Such a mechanism could help the virus to maintain its long-term presence within the human population. Our findings could also be applied to the development of novel anti-influenza therapies that will interfere in a highly selective fashion with the NS1 tail binding to its chromatin partners. Finally, identification of hPAF1C as a key mediator of antiviral and pro-inflammatory gene response may pave the way for the development of anti-inflammatory therapies that-similar to the recently described 'epigenetic' therapies 8, 9 -will interfere selectively with hPAF1C binding to its partners.
METHODS SUMMARY
The methylation and acetylation in vitro has been performed as described previously 12, 26 . The analysis of NS1 methylation or acetylation in vivo has been done by using custom-made methyl-specific or commercial acetyl-specific antibodies 27 . Isolation of the NS1 binding proteins, their analysis by mass-spectrometry and western blotting were performed according to a protocol used to identify histonebound proteins 34 . The recombinant hPAF1C and its individual components were prepared as described before 36 . Interaction between hPAF1C and its individual components with peptides were performed as reported 32, 33 . The transcriptional assays have been performed as described 36 . Genome-wide distribution of NS1 and other chromatin-bound proteins were accessed by ChIP-sequencing as previously described 9 , and analysed using standard bioinformatic approaches. Recombinant influenza viruses were generated using standard reverse genetics approaches 15, 17 . Infection of cells with viruses was performed according to the standard methods 17, 46 and viral titres were quantified by plaque assay. Gene expression analysis has been done by microarray using Illumina Human HT-12 v4 Expression BeadChips or by RNA-sequencing and verified by quantitative realtime PCR 9 . GRO-sequencing was performed as described 41 . All methodological details are additionally outlined in Supplementary Information.
